Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Puma Biotech (PBYI) Q4 Loss Wider Than Expected, Sales Top
Puma Biotechnology and Pierre Fabre Enter into Exclusive License Agreement to Develop and Commercialize NERLYNX® (neratinib) in Europe | Business Wire
Puma Biotechnology (PBYI) - 5 Price Charts 2012-2023 (History)
Is Puma Biotechnology, Inc. (NASDAQ:PBYI) Popular Amongst Insiders?
Chris Culotta - Associate Director, Accounting - Puma Biotechnology, Inc. | LinkedIn
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Biotechnology, Inc. | CDISC
Articles with Puma Biotechnology
Federal Jury Awards Puma Biotechnology Investors Damages in Securities Class-Action Verdict - Los Angeles Business Journal
Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology, Inc. 2022 Q4 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology, Inc. 2020 Q1 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | Fox Business
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology
Puma Biotechnology's (PBYI) Lowest Price: $1.6400 (on 05-11-2022)
Puma Biotechnology, Inc.
Former Puma Biotech Executive Gets U.S. Prison Term for Insider Trading
Puma Biotechnology Inc. | BioWorld
Puma Biotechnology
Puma Biotechnology, Inc.
Puma Biotech agrees to pay investors $54.2 mln in fraud case | Reuters
Goldman Sachs Group Cuts Stake in Puma Biotechnology (PBYI)
Puma Biotechnology: Too Little, Too Late, Too Much Of A Bad Side Effect (NASDAQ:PBYI) | Seeking Alpha
